Skip to Main Content

Author Details

Edward J Mills
McMaster University
2001
441
80
PMIDPaper TitleJournal TitlePublished Year
36563700Advancing detection and response capacities for emerging and re-emerging pathogens in Africa.Lancet Infect Dis2023
37506723Global HIV control: is the glass half empty or half full?Lancet HIV2023
37580027The Human Mpox Global Outbreak: Available Control Tools and the Opportunity to Break a Cycle of Neglect in Endemic Countries.Am J Trop Med Hyg2023
37089453The effect of group support psychotherapy on adherence to anti-retroviral therapy and viral suppression among HIV positive young people: Study protocol for a pilot randomized controlled trial.Front Health Serv2023
37069219The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials.Commun Med (Lond)2023
37068273Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 : A Randomized Platform Trial.Ann Intern Med2023
36780676Early Treatment with Pegylated Interferon Lambda for Covid-19.N Engl J Med2023
36702150Estimating HIV incidence in sub-Saharan Africa.Lancet HIV2023
34717820Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial.Lancet Glob Health2022
35834528A randomized control trial of high-dose micronutrient-antioxidant supplementation in healthy persons with untreated HIV infection.PLoS One2022
35819785Economic Evaluation of Cost and Time Required for a Platform Trial vs Conventional Trials.JAMA Netw Open2022
35445964Interferon Treatments for SARS-CoV-2: Challenges and Opportunities.Infect Dis Ther2022
35353979Effect of Early Treatment with Ivermectin among Patients with Covid-19.N Engl J Med2022
36530913Use of trained scent dogs for detection of COVID-19 and evidence of cost-saving.Front Med (Lausanne)2022
36233753Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19.J Clin Med2022
36130257Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis.Clin Infect Dis2022
36379209Early Treatment with Fluvoxamine among Patients with COVID-19: A Cost-Consequence Model.Am J Trop Med Hyg2022
36162067Long-Term Effect of Group Support Psychotherapy on Depression and HIV Treatment Outcomes: Secondary Analysis of a Cluster Randomized Trial in Uganda.Psychosom Med2022
36375450Toward a New Paradigm of North-South and South-South Partnerships for Pandemic Preparedness: Lessons Learned from COVID-19 and Other Outbreaks.Am J Trop Med Hyg2022
35044430Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries.JAMA Pediatr2022
34982138How to Use and Interpret the Results of a Platform Trial: Users' Guide to the Medical Literature.JAMA2022
35180413Fluvoxamine for the treatment of COVID-19 - Author's reply.Lancet Glob Health2022
35303472Evaluating COVID-19 vaccines in the real world.Lancet2022
34996047Resilient Clinical Trial Infrastructure in Response to the COVID-19 Pandemic: Lessons Learned from the TOGETHER Randomized Platform Clinical Trial.Am J Trop Med Hyg2022
35202049Brief Report: Active HIV Case Finding in the City of Kigali, Rwanda: Assessment of Voluntary Assisted Partner Notification Modalities to Detect Undiagnosed HIV Infections.J Acquir Immune Defic Syndr2022
34927127Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trial.Lancet Reg Health Am2022
33236703The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19.Am J Trop Med Hyg2021
33910502Towards elimination of mother-to-child transmission of HIV in Rwanda: a nested case-control study of risk factors for transmission.BMC Pregnancy Childbirth2021
33684053Clinical Trial Data Sharing for COVID-19-Related Research.J Med Internet Res2021
33865475The role and challenges of cluster randomised trials for global health.Lancet Glob Health2021
33865476How COVID-19 has fundamentally changed clinical research in global health.Lancet Glob Health2021
33865473Urgently seeking efficiency and sustainability of clinical trials in global health.Lancet Glob Health2021
33865474Randomised trials at the level of the individual.Lancet Glob Health2021
33580256The Critical Need for Pooled Data on Coronavirus Disease 2019 in African Children: An AFREhealth Call for Action Through Multicountry Research Collaboration.Clin Infect Dis2021
33555032Model-Informed Drug Development for Anti-Infectives: State of the Art and Future.Clin Pharmacol Ther2021
33885775Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial.JAMA Netw Open2021
33975886Child mortality associated with maternal HIV status: a retrospective analysis in Rwanda, 2005-2015.BMJ Glob Health2021
34000408Moving forward in clinical research with master protocols.Contemp Clin Trials2021
34164926Mental health interventions for persons living with HIV in low- and middle-income countries: a systematic review.J Int AIDS Soc2021
33279656Reporting and design of randomized controlled trials for COVID-19: A systematic review.Contemp Clin Trials2021
32323646Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings.Am J Trop Med Hyg2020
34415559Correction to: Early Treatment of COVID-19 Disease: A Missed Opportunity.Infect Dis Ther2020
32031692An overview of precision oncology basket and umbrella trials for clinicians.CA Cancer J Clin2020
32035035Effectiveness and cost-effectiveness of group support psychotherapy delivered by trained lay health workers for depression treatment among people with HIV in Uganda: a cluster-randomised trial.Lancet Glob Health2020
33376364The Landscape of Emerging Randomized Clinical Trial Evidence for COVID-19 Disease Stages: A Systematic Review of Global Trial Registries.Infect Drug Resist2020
33051827Early Treatment of COVID-19 Disease: A Missed Opportunity.Infect Dis Ther2020
33303482The time to act is now: pseudo-systematic review.BMJ2020
33090634Utilizing Bayesian predictive power in clinical trial design.Pharm Stat2020
32828171Clinical trials of disease stages in COVID 19: complicated and often misinterpreted.Lancet Glob Health2020
32828137Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19.Am J Trop Med Hyg2020
  • 1 - 50 of 441

Recommended Authors

Maria Mazzitelli
Padua University Hospital
Career Start Year 2016
Number of shared co-authors 0
Onyema Ogbuagu
Yale School of Medicine, Yale University
Career Start Year 2014
Number of shared co-authors 0
Juan Pablo Domecq
Mayo Clinic
Career Start Year 2011
Number of shared co-authors 3
Sara H Bares
University of Nebraska Medical Center
Career Start Year 2011
Number of shared co-authors 0
Tracy L Nolen
Research Triangle Institute.
Career Start Year 2009
Number of shared co-authors 1
Allison DeLong
School of Public Health, Brown University
Career Start Year 2007
Number of shared co-authors 2
Scott R Evans
Milken Institute School of Public Health, George Washington University
Career Start Year 2002
Number of shared co-authors 2
Vincent Lo Re
IRCCS-ISMETT
Career Start Year 2001
Number of shared co-authors 5
Scarlett L Bellamy
Dornsife School of Public Health, Drexel University.
Career Start Year 2000
Number of shared co-authors 1
Tassos C Kyriakides
Yale School of Public Health
Career Start Year 1999
Number of shared co-authors 0
Sean Philpott
Clarkson University
Career Start Year 1999
Number of shared co-authors 0
Susanne May
University of Washington
Career Start Year 1998
Number of shared co-authors 0
Sonia Jain
University of California San Diego
Career Start Year 1997
Number of shared co-authors 4
David A Wohl
The University of North Carolina School of Medicine
Career Start Year 1997
Number of shared co-authors 10
Rochelle P Walensky
Massachusetts General Hospital
Career Start Year 1996
Number of shared co-authors 3
Charles B Hare
Kaiser Permanente San Francisco Medical Center
Career Start Year 1994
Number of shared co-authors 0
Sally C Morton
Virginia Commonwealth University
Career Start Year 1993
Number of shared co-authors 4
Cathie Spino
University of Michigan ann arbor
Career Start Year 1991
Number of shared co-authors 3
Paul M Coplan
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1990
Number of shared co-authors 0
Jonathan A C Sterne
University of Bristol
Career Start Year 1988
Number of shared co-authors 5
Susan Swindells
University of Nebraska Medical Center
Career Start Year 1987
Number of shared co-authors 2
Ian Frank
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 2
Robert A Parker
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 2
Robert Colebunders
Global Health Institute, University of Antwerp
Career Start Year 1982
Number of shared co-authors 7
Peter Bacchetti
University of California San Francisco
Career Start Year 1981
Number of shared co-authors 3
Florin Vaida
School of Public Health, university of california san diego
Career Start Year 1980
Number of shared co-authors 0
Andy Stergachis
School of Pharmacy, University of Washington
Career Start Year 1980
Number of shared co-authors 2
Michael S Saag
University of Alabama at Birmingham
Career Start Year 1980
Number of shared co-authors 4
Ross E McKinney
Duke University Medical Center
Career Start Year 1979
Number of shared co-authors 0
Dushyantha Jayaweera
University of Miami, Miller School of Medicine
Career Start Year 1977
Number of shared co-authors 3

Collaborators

Kristian Thorlund
McMaster University
Co-authored papers 73
Ofir Harari
Cytel Inc.
Co-authored papers 21
Andre Pascal Kengne
Non-Communicable Diseases Research Unit, South African Medical Research Council
Co-authored papers 16
Victor M Montori
Knowledge and Evaluation Research Unit in Endocrinology (KER_Endo), Mayo Clinic
Co-authored papers 14
Jean-Jacques Muyembe-Tamfum
National Institute of Biomedical Research (INRB)
Co-authored papers 8
John P A Ioannidis
Stanford University
Co-authored papers 8
Steven E Lipshultz
University at Buffalo Jacobs School of Medicine and Biomedical Sciences
Co-authored papers 5
Sanjay Basu
The Pirbright Institute
Co-authored papers 5
Eric L Ding
Co-authored papers 5
Jon O Ebbert
Mayo Clinic
Co-authored papers 5
David R Bangsberg
Co-authored papers 5
David R Boulware
University of Minnesota
Co-authored papers 5
Jasvinder A Singh
University of Alabama at Birmingham
Co-authored papers 5
Saad B Omer
Yale School of Public Health
Co-authored papers 4
Km Venkat Narayan
Rollins School of Public Health, Emory University
Co-authored papers 4
Robert Gross
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 4
Philip J Rosenthal
University of California at San Francisco
Co-authored papers 4
Duane A Quistberg
Drexel University
Co-authored papers 4
Cyrus Cooper
Co-authored papers 4
Heresh Amini
Co-authored papers 4
Joel J Gagnier
University of Michigan ann arbor
Co-authored papers 4
David Moher
University of Ottawa
Co-authored papers 4
Jeffrey A Towbin
University of Tennessee Health Science Center
Co-authored papers 3
George A Mensah
and Blood Institute
Co-authored papers 3
Abraham D Flaxman
Institute for Health Metrics and Evaluation, University of Washington
Co-authored papers 3
Rajiv Chowdhury
Co-authored papers 3
Dorairaj Prabhakaran
Co-authored papers 3
Neill K J Adhikari
University of Toronto
Co-authored papers 3
Elizabeth J Phillips
Vanderbilt University Medical Center
Co-authored papers 3
Coen H van Gool
National Institute for Public Health and the Environment
Co-authored papers 3
Release 1.2